Aristotle Funds, an investment advisor, released its “Growth Equity Fund” fourth-quarter 2025 investor letter. A copy of the letter can be downloaded here. U.S. equity markets reached new all-time highs in Q4 2025, with the S&P 500 Index rising 2.66% and the Bloomberg U.S. Aggregate Bond Index increasing by 1.10%. Within the Russell 1000 Growth Index, healthcare, communication services, and financials were the top-performing sectors, while utilities, real estate, and materials lagged. The U.S. economy show ...

Adjusted EBITDA loss narrowed to $64.9 million in Q4 from $78.4 million in the prior-year quarter. For the full year, adjusted EBITDA loss improved to $220.9 million versus $257.5 million in 2024.Management attributed the performance to “broad-based growth” across oncology, screening, and the biopharma and data segment. The company reported non-GAAP gross margin of 66% in Q4, up from 63% a year earlier, and 66% for the full year, up from 62% in 2024.Guardant said total revenue increased 39% year over year t ...

Core Viewpoint - Gamehost Inc. has announced a cash dividend of $0.05 (CDN) per common share for February 2026, which translates to an annualized rate of $0.60 (CDN) per share, to be paid on March 13, 2026, to shareholders of record on February 28, 2026 [1][2]. Company Overview - Gamehost Inc. is incorporated under the laws of Alberta, Canada, and operates various facilities including the Rivers Casino & Entertainment Centre in Ft. McMurray, the Great Northern Casino, Service Plus Inns & Suites, Encore Suites hotels, and the Deerfoot Inn & Casino in Calgary [3][4]. - The company's common shares are traded on the Toronto Stock Exchange (TSX) under the symbol GH [4].

Carillon Tower Advisers, an investment management company, released its fourth-quarter 2025 investor letter for the “Carillon Eagle Small Cap Growth Fund”. You can download a copy of the letter here. Small-cap stocks delivered marginal gains in the fourth quarter of 2025. The Russell 2000® Value Index outperformed the Russell 2000® Growth Index in the quarter, with more balanced results. In line with the broader stock market, small-cap stocks delivered solid results in 2025. The Russell 2000 Growth Index re ...

Core Insights - Guardant Health has launched a Community Colorectal Cancer Screening Grant Program to enhance access to colorectal cancer screening during March, which is Colorectal Cancer Awareness Month [1] - The program will provide selected organizations with up to 100 Shield tests at no cost to support community health fairs, screening events, and educational outreach [1] - Shield is the first FDA-approved blood test for colorectal cancer screening for adults aged 45 and older at average risk, offering a more convenient option compared to traditional methods [1] Company Initiatives - The grant program aims to remove barriers to screening, particularly in underserved communities, and supports organizations that focus on health outreach [1] - Applications for the grant are open until February 17, 2026, with notifications of approval sent on February 20, 2026 [1] - Organizations interested in applying are encouraged to review the Request for Proposals and complete the application form [1] Product Information - Shield is a non-invasive blood-based screening test that detects alterations associated with colorectal cancer, intended for individuals aged 45 and older at average risk [1] - A positive result from the Shield test indicates the need for further evaluation through colonoscopy [1] - Guardant Health is focused on transforming patient care and accelerating cancer therapies through advanced testing and analytics [1]

Core Insights - Adaptive Biotechnologies reported a quarterly loss of $0.09 per share, outperforming the Zacks Consensus Estimate of a loss of $0.19, and showing improvement from a loss of $0.23 per share a year ago, resulting in an earnings surprise of +52.63% [1] - The company achieved revenues of $71.68 million for the quarter ended December 2025, which was slightly below the Zacks Consensus Estimate by 0.44%, but represented a significant increase from $47.46 million in the same quarter last year [2] - The stock has gained approximately 6.5% since the beginning of the year, outperforming the S&P 500's gain of 0.5% [3] Earnings Outlook - The earnings outlook for Adaptive Biotechnologies is mixed, with the current consensus EPS estimate for the upcoming quarter at -$0.17 on revenues of $61.01 million, and for the current fiscal year at -$0.59 on revenues of $266.15 million [7] - The company's Zacks Rank is currently 3 (Hold), indicating expected performance in line with the market in the near future [6] Industry Context - The Medical - Biomedical and Genetics industry, to which Adaptive Biotechnologies belongs, is currently ranked in the top 37% of over 250 Zacks industries, suggesting a favorable outlook compared to lower-ranked industries [8] - Another company in the same industry, Guardant Health, is expected to report a quarterly loss of $0.42 per share, reflecting a year-over-year change of +32.3%, with revenues anticipated to be $279.96 million, up 38.7% from the previous year [9][10]

Fred Alger Management, an investment management company, released its “Alger Small Cap Focus Fund” fourth-quarter 2025 investor letter. A copy of the letter can be downloaded here. The US equity market ended the fourth quarter on a strong note, with the S&P surging 2.7%, maintaining its steady upward momentum. Investors' optimism was supported by better-than-expected corporate earnings, the US Federal Reserve’s further interest rate easing stance, and a resilient macroeconomic backdrop. Improving clarity on ...

Core Insights - Guardant Health, Inc. is ranked fifth in a list of the Top 10 Oncology Stocks to Buy Now, indicating strong market interest and potential for growth [1] - Analysts from Stifel and Mizuho have raised their price targets for Guardant Health, with Stifel increasing it to $120 and Mizuho to $135, reflecting positive sentiment and expectations for future performance [2][3] Company Overview - Guardant Health, Inc. specializes in precision oncology, focusing on non-invasive liquid biopsy tests for cancer detection, treatment selection, and disease monitoring [3] - The company's flagship products, Guardant360 and Guardant Shield, facilitate early cancer detection, biomarker profiling, and real-time monitoring, which are essential for personalized cancer care [3] Market Expectations - Stifel anticipates strong volume and average selling price growth for Guardant Health in 2026, supported by publication and reimbursement events that are expected to maintain investor interest [1] - Mizuho has revised its models for the diagnostics and medical device sectors, indicating a broader positive outlook for the industry in which Guardant operates [2]

Core Points - Gamehost Inc. has declared a cash dividend of $0.05 (CDN) per common share for January 2026, which annualizes to $0.60 (CDN) per share [1] - The dividend will be paid on February 13, 2026, to shareholders of record on January 31, 2026 [1] - This dividend is classified as an "Eligible Dividend," allowing Canadian shareholders to benefit from enhanced gross-up and dividend tax credits [2] Company Overview - Gamehost Inc. is incorporated under the laws of Alberta, Canada, and operates various facilities within the province, including the Rivers Casino & Entertainment Centre, Great Northern Casino, Service Plus Inns & Suites, Encore Suites hotels, and Deerfoot Inn & Casino [3] - The company's common shares are traded on the Toronto Stock Exchange (TSX) under the symbol GH [4]

Core Points - Gamehost Inc. has had a temporary increase in slot commissions from 15% to 17%, effective from April 1, 2023, to March 31, 2025, which has now been extended for an additional three years until March 31, 2029, to promote investment in marketing and site improvements [1] - The Alberta Gaming, Liquor and Cannabis (AGLC) announcement also allows land-based casinos to partner with Play Alberta for retail sportsbook opportunities [1] Company Overview - Gamehost Inc. is incorporated under the laws of Alberta, Canada, and operates various facilities including the Rivers Casino & Entertainment Centre in Ft. McMurray, the Great Northern Casino, Service Plus Inns & Suites, Encore Suites hotels, and the Deerfoot Inn & Casino in Calgary [2] - The company's common shares are traded on the Toronto Stock Exchange (TSX) under the symbol GH [3]